@jimharty @austinpbyrne @drdavidsamadi thanks Jim. Latest publication here: https://t.co/XWuzh8JFZk
RT @drdhanlon: The PSA Dilemma just got worse https://t.co/SLhn1vgoZm @ICGPnews
Effectiveness of treatments for PSA detected prostate cancer. 10 year survival unaffected by treatment! https://t.co/FpSougZlto
RT @drdhanlon: The PSA Dilemma just got worse https://t.co/SLhn1vgoZm @ICGPnews
Has anyone had a chance to evaluate new NEJM paper, active monitoring vs surgery or rads #prostate CA?#pathJC https://t.co/B1UL0O5JVJ
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer https://t.co/Pyx7W0eIiQ via @NEJM
RT @CaulfieldTim: Prostate cancer study: Monitoring, surgery, or radiotherapy? No difference in outcome: https://t.co/FHaJyVOKiI #ChooseWis…
RT @WilliamDale_MD: Prostate cancer is now a chronic disease. #GeriOnc https://t.co/SlNC0Xp9iN
RT @WilliamDale_MD: Prostate #cancer as a chronic disease. #GeriOnc https://t.co/yGutb2JLz3
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized #Prostate Cancer — NEJM https://t.co/pOCH6zSFqL
RT @drdhanlon: The PSA Dilemma just got worse https://t.co/SLhn1vgoZm @ICGPnews
The PSA Dilemma just got worse https://t.co/SLhn1vgoZm @ICGPnews
RT @finn_corinne: Amazing study. We now need to obtain similar data in early stage NSCLC with SABR https://t.co/EPBuH8aN5U
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @finn_corinne: Amazing study. We now need to obtain similar data in early stage NSCLC with SABR https://t.co/EPBuH8aN5U
RT @fischmd: Mortality was low irrespective of the treatment assigned (surgery, XRT, or active monitoring), #pcsm https://t.co/gS5fb8ujUo
RT @TCDRadTher: Excellent long term results of radiation therapy for prostate cancer. https://t.co/gL6VBNFi6M
Mortality was low irrespective of the treatment assigned (surgery, XRT, or active monitoring), #pcsm https://t.co/gS5fb8ujUo
RT @Newhealthpsych: It's not easy being a patient - or a doctor - the evidence keeps changing https://t.co/ggmBifhW3F
RT @WilliamDale_MD: Prostate #cancer as a chronic disease. #GeriOnc https://t.co/yGutb2JLz3
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/yuMOv3IjpO
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @_JosephLi: Surgery, radiation & active monitoring all assoc w low mortality in localized prostate CA: a 10 yr study https://t.co/BXzBRI…
RT @AEDeGraciaNieto: This may be the end of active survilance in prostate cancer. What do you think? @uroweb @infoAEU https://t.co/WQm4lOtC…
Must read.. 10 year outcomes https://t.co/3dm2k32J0x
RT @AEDeGraciaNieto: This may be the end of active survilance in prostate cancer. What do you think? @uroweb @infoAEU https://t.co/WQm4lOtC…
RT @AEDeGraciaNieto: This may be the end of active survilance in prostate cancer. What do you think? @uroweb @infoAEU https://t.co/WQm4lOtC…
RT @AEDeGraciaNieto: This may be the end of active survilance in prostate cancer. What do you think? @uroweb @infoAEU https://t.co/WQm4lOtC…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/Va5VSvPcVM
The lack of precision of the prostate bx, concerning the gleason ectetx, doubts AS https://t.co/KYHFhicRrC
Still questions? 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/WUfIn5b4tI
This may be the end of active survilance in prostate cancer. What do you think? @uroweb @infoAEU https://t.co/WQm4lOtC40
RT @sandraturner49: Radiation therapy as good as surgery for prostate cancer. @JillMargo1 @TargetingCancer @cancerNSW @DrTPShakespeare http…
RT @sandraturner49: Radiation therapy as good as surgery for prostate cancer. @JillMargo1 @TargetingCancer @cancerNSW @DrTPShakespeare http…
RT @SimonGandevia: Monitoring: Prostate cancer mortality is same with monitoring, radiotherapy or SURGERY with 10 years of follow up. https…
RT @SimonGandevia: Monitoring: Prostate cancer mortality is same with monitoring, radiotherapy or SURGERY with 10 years of follow up. https…
Monitoring: Prostate cancer mortality is same with monitoring, radiotherapy or SURGERY with 10 years of follow up. https://t.co/bxFoRJWpSn
Monitoring: Prostate cancer mortality is same with monitoring, radiotherapy or SURGERY with 10 years of follow up. https://t.co/HfSuU7rLen
Freddie Hamdy et al 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/VgNJ3IBDpv
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
Localisierter Prostata #Krebs: Beobachten oft sinnvolle Alternative zur Operation — NEJM https://t.co/JySRxK5imS
Men w/ localized prostate cancer treated aggressively v monitored have virtually the same rate of 10yr survival https://t.co/6UgIqwYITU
RT @_sarahweller: Prostate cancer survival study: surgery vs radiation vs active surveillance https://t.co/RgelYKGTGS study: https://t.co/Q…
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @quequesierra: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer https://t.co/hs3tkRxC2E https:/…
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/fxhzbWygZm
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/sm16HA24G0
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/M5f5u6D6JP
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/ytFyV6JxQi
RT @Monthy_A: Treating Prostate Cancer Associated with Lower Incidences of Progression and Metastases than Active Monitoring https://t.co/G…
RT @Monthy_A: Level 1 evidence that PSA monitoring vs treatment of early prostate cancer leads to increased metastasis https://t.co/G2qaxzK…
RT @hseino1: 原著論文はこちらhttps://t.co/8sKYpatfO5。一般的ながん検診の有効の議論はこちら「がん検診についてhttps://t.co/xDh1PGIGhq」/初期の前立腺がん 治療の有無で生存率にほぼ差なしhttps://t.co/7ktUK…
RT @alfonso_casi: Resultados a 10 años del cáncer de próstata localizado mediante supervisión activa, cirugía o radioterapia. https://t.co/…
RT @RaulCalvoRico: 1,5/1000 fallecidos año x Ca d próstata si sólo se monitoriza. 0,9 si prostatectomia radical, 0,7 si radioterapia. http…
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @UrologyUS: Study shows 99% survival rate on #ProstateCancer treatments. Now we need to determine what it means for patient care.https:/…
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
Study shows 99% survival rate on #ProstateCancer treatments. Now we need to determine what it means for patient care.https://t.co/bADlA1BEhl
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
10-year outcome local prostate cancer with/without intervention in men 50-69 years old: 1 per 1000 dies of disease. https://t.co/AbrLpQW2jl
Lokale prostaatkanker wel/niet behandeld bij mannen 50-69 jaar oud: In 10 jaar overlijdt: 1 per 1000 aan ziekte. https://t.co/w2BVak14bk
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @UICUrol: Important study on prostate cancer outcomes. @NEJM https://t.co/iNG7kznG7F
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @NEJM: Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
Original Article: PSA-Detected #ProstateCancer — To Treat or Not to Treat https://t.co/nlI4wTKhlu https://t.co/SzXt3YPHsu
RT @MaryDixonWoods: Huge, lengthy trial of interventions for clinically localized prostate cancer reports. https://t.co/mFVbzuPjjA
RT @CSR_Bris: The RCT they said could never be done: ProtecT published in NEJM.https://t.co/6rLH9ognpB https://t.co/NRiBZHUcy9
Excellent long term results of radiation therapy for prostate cancer. https://t.co/gL6VBNFi6M
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/kTxJRlqNbi
NEJM #prostatecancer ProtecT trial outcomes: https://t.co/WX3ZJSPLj5 https://t.co/GQlpVwxw37
RT @Monthy_A: Tratamiento con radioterapia/cirugía del cáncer de próstata precoz, mejor que vigilancia activa con PSA https://t.co/G2qaxzKc…
A: Treat cancer only if benefits > harms. For PrCa, surveillance = surgery = radiotherapy https://t.co/85n0oUsy8w https://t.co/vWd9DyloXD
Tratamiento con radioterapia/cirugía del cáncer de próstata precoz, mejor que vigilancia activa con PSA https://t.co/G2qaxzKciJ
Level 1 evidence that PSA monitoring vs treatment of early prostate cancer leads to increased metastasis https://t.co/cIK1nQmTcP
Level 1 evidence that PSA monitoring vs treatment of early prostate cancer leads to increased metastasis https://t.co/G2qaxzKciJ
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
Treating Prostate Cancer Associated with Lower Incidences of Progression and Metastases than Active Monitoring https://t.co/G2qaxzKciJ
Treating Prostate Cancer Associated with Lower Incidences of Progression and Metastases than Active Monitoring https://t.co/cIK1nQmTcP
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer https://t.co/G2qaxzKciJ
Will biomarkers help? 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Ca https://t.co/AFfCftS3QJ